Ruimin Pan

Ruimin Pan

Auto-generated profile, based on publicly available information

Ruimin Pan

Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2018 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
SLSakaorat Lertjuthaporn
Sakaorat Lertjuthaporn
CCClaudia Cicala
Claudia Cicala
DRDonald Van Ryk
Donald Van Ryk
MLMatthew Liu
Matthew Liu
JYJason Yolitz
Jason Yolitz
JAJames Arthos
James Arthos
The GI tract is preferentially targeted during acute/early HIV-1 infection. Consequent damage to the gut plays a central role in HIV pathogenesis. The basis for preferential targeting of gut tissues is not well defined. Recombinant proteins and synthetic peptides derived from HIV and SIV gp120 bind directly to integrin α4β7, a gut-homing receptor. Using both cell-surface expressed α4β7 and a soluble α4β7 heterodimer we demonstrate that its specific affinity for gp120 is similar to its affinity for MAdCAM (its natural ligand). The gp120 V2 domain preferentially engages extended forms of α4β7 in a cation -sensitive manner and is inhibited by soluble MAdCAM. Thus, V2 mimics MAdCAM in the way that it binds to α4β7, providing HIV a potential mechanism to discriminate between functionally distinct subsets of lymphocytes, including those with gut-homing potential. Furthermore, α4β7 antagonists developed for the treatment of inflammatory bowel diseases, block V2 binding to α4β7. A 15-amino acid V2 -derived peptide is sufficient to mediate binding to α4β7. It includes the canonical LDV/I α4β7 binding site, a cryptic epitope that lies 7–9 amino acids amino terminal to the LDV/I, and residues K169 and I181. These two residues were identified in a sieve analysis of the RV144 vaccine trial as sites of vaccine -mediated immune pressure. HIV and SIV V2 mAbs elicited by both vaccination and infection that recognize this peptide block V2-α4β7 interactions. These mAbs recognize conformations absent from the β- barrel presented in a stabilized HIV SOSIP gp120/41 trimer. The mimicry of MAdCAM-α4β7 interactions by V2 may influence early events in HIV infection, particularly the rapid seeding of gut tissues, and supports the view that HIV replication in gut tissue is a central feature of HIV pathogenesis. HIV is gut-tropic. Disruption of GALT plays an important role in HIV -mediated immune dysfunction. α4β7 is a receptor that facilitates homing of lymphocytes to GALT. α4β7high CD4+ T cells are early targets of HIV infection. The HIV envelope protein gp120 binds to α4β7; however, a link between this interaction and the preferential infection of α4β7high CD4+ T cells has not been established. Here we report an apparent gp120 mimicry of MAdCAM, a natural ligand of α4β7. That the HIV envelope protein mimics an adhesion receptor expressed primarily in gut tissues supports the concept of a central role for GALT in HIV pathogenesis. Antibodies derived from vaccination and infection were evaluated for their capacity to inhibit gp120-α4β7 interactions. Antibodies that inhibit binding target a region of the V2 domain that has been linked with reduced risk of acquisition in the RV144 vaccine trial. These antibodies recognize epitopes that do not appear on the closed gp120/41 trimer. Instead, they recognize structures that form when V2 is allowed to fold in a less constrained way. We show that such epitopes can appear on virions. Thus, an alternative structure of the V2 domain may facilitate the trafficking of HIV to GALT.

1 June 2020 in Cell Host & Microbe
Verified
Journal Article
Open access
MJManxue Jia
Manxue Jia
RLRachel Liberatore
Rachel Liberatore
YGYicheng guo
Yicheng guo
KCKun-Wei Chan
Kun-Wei Chan
RPRuimin Pan
Ruimin Pan
Xueling WuXueling Wu
Xueling Wu
The HIV-1 envelope (Env) undergoes conformational changes during infection. Broadly neutralizing antibodies (bNAbs) are typically isolated by using soluble Env trimers, which do not capture all Env states. To address these limitations, we devised a vesicular stomatitis virus (VSV)-based probe to display membrane-embedded Env trimers and isolated five bNAbs from two chronically infected donors, M4008 and M1214. Donor B cell receptor (BCR) repertoires identified two bNAb lineages, M4008_N1 and M1214_N1, that class-switched to immunoglobulin G (IgG) and IgA. Variants of these bNAbs reconstituted as IgA demonstrated broadly neutralizing activity, and the IgA fraction of M1214 plasma conferred neutralization. M4008_N1 epitope mapping revealed a glycan-independent V3 epitope conferring tier 2 virus neutralization. A 4.86-Å-resolution cryogenic electron microscopy (cryo-EM) structure of M1214_N1 complexed with CH505 SOSIP revealed another elongated epitope, the V2V5 corridor, extending from V2 to V5. Overall, the VSVENV probe identified bNAb lineages with neutralizing IgG and IgA members targeting distinct sites of HIV-1 Env vulnerability.